Colony Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $8.63M | Sell |
17,044
-93
| -0.5% | -$49.6K | 0.13% | 157 |
|
|
2023
Q2 | $8.94M | Buy |
17,137
+42
| +0.2% | +$22.7K | 0.13% | 163 |
|
|
2023
Q1 | $9.85M | Sell |
17,095
-4,285
| -20% | -$2.42M | 0.15% | 145 |
|
|
2022
Q4 | $11.8M | Buy |
21,380
+3,708
| +21% | +$1.96M | 0.17% | 139 |
|
|
2022
Q3 | $8.96M | Sell |
17,672
-115
| -0.6% | -$64.4K | 0.16% | 137 |
|
|
2022
Q2 | $9.66M | Sell |
17,787
-630
| -3% | -$347K | 0.17% | 129 |
|
|
2022
Q1 | $10.9M | Buy |
18,417
+3,685
| +25% | +$2.12M | 0.16% | 132 |
|
|
2021
Q4 | $9.83M | Buy |
14,732
+6,797
| +86% | +$4.24M | 0.17% | 108 |
|
|
2021
Q3 | $4.53M | Sell |
7,935
-107
| -1% | -$58.7K | 0.09% | 190 |
|
|
2021
Q2 | $4.06M | Sell |
8,042
-580
| -7% | -$274K | 0.08% | 198 |
|
|
2021
Q1 | $3.94M | Buy |
8,622
+156
| +2% | +$74.5K | 0.08% | 204 |
|
|
2020
Q4 | $3.94M | Sell |
8,466
-1,079
| -11% | -$506K | 0.09% | 194 |
|
|
2020
Q3 | $4.21M | Sell |
9,545
-37
| -0.4% | -$15.3K | 0.11% | 171 |
|
|
2020
Q2 | $3.47M | Buy |
9,582
+2,127
| +29% | +$713K | 0.1% | 180 |
|
|
2020
Q1 | $2.11M | Sell |
7,455
-1,722
| -19% | -$543K | 0.07% | 234 |
|
|
2019
Q4 | $2.98M | Sell |
9,177
-506
| -5% | -$153K | 0.08% | 234 |
|
|
2019
Q3 | $2.82M | Sell |
9,683
-336
| -3% | -$96.2K | 0.09% | 214 |
|
|
2019
Q2 | $2.94M | Buy |
10,019
+5,941
| +146% | +$1.64M | 0.09% | 208 |
|
|
2019
Q1 | $1.12M | Buy |
4,078
+151
| +4% | +$37.6K | 0.05% | 279 |
|
|
2018
Q4 | $879K | Sell |
3,927
-163
| -4% | -$38.2K | 0.04% | 275 |
|
|
2018
Q3 | $998K | Sell |
4,090
-352
| -8% | -$81K | 0.05% | 268 |
|
|
2018
Q2 | $920K | Buy |
4,442
+933
| +27% | +$198K | 0.05% | 270 |
|
|
2018
Q1 | $724K | Sell |
3,509
-134
| -4% | -$28.1K | 0.04% | 282 |
|
|
2017
Q4 | $692K | Sell |
3,643
-9
| -0.2% | -$1.72K | 0.04% | 274 |
|
|
2017
Q3 | $691K | Sell |
3,652
-41
| -1% | -$7.42K | 0.05% | 251 |
|
|
2017
Q2 | $644K | Buy |
+3,693
| New | +$620K | 0.05% | 259 |
|
|
2017
Q1 | – | Sell |
-2,631
| Closed | -$371K | – | 299 |
|
|
2016
Q4 | $371K | Buy |
2,631
+20
| +0.8% | +$2.95K | 0.04% | 217 |
|
|
2016
Q3 | $415K | Buy |
2,611
+356
| +16% | +$54.9K | 0.05% | 195 |
|
|
2016
Q2 | $333K | Buy |
2,255
+360
| +19% | +$53.1K | 0.04% | 193 |
|
|
2016
Q1 | $268K | Sell |
1,895
-1,005
| -35% | -$135K | 0.03% | 211 |
|
|
2015
Q4 | $411K | Buy |
2,900
+2,750
| +1,833% | +$367K | 0.04% | 276 |
|
|
2015
Q3 | $18K | Hold |
150
| – | – | ﹤0.01% | 556 |
|
|
2015
Q2 | $19K | Sell |
150
-125
| -45% | -$16.3K | ﹤0.01% | 546 |
|
|
2015
Q1 | $37K | Sell |
275
-451
| -62% | -$58.1K | ﹤0.01% | 457 |
|
|
2014
Q4 | $91K | Sell |
726
-586
| -45% | -$71.3K | 0.01% | 390 |
|
|
2014
Q3 | $160K | Buy |
1,312
+34
| +3% | +$4.13K | 0.02% | 332 |
|
|
2014
Q2 | $151K | Buy |
1,278
+385
| +43% | +$45.3K | 0.02% | 235 |
|
|
2014
Q1 | $107K | Sell |
893
-32
| -3% | -$3.8K | 0.01% | 261 |
|
|
2013
Q4 | $103K | Buy |
+925
| New | +$92K | 0.01% | 258 |
|
Other funds holding TMO
Colony Group's TMO Position: Q3 2023 in Review
Colony Group reduced its Thermo Fisher Scientific (TMO) stake by 0.54% in Q3 2023, selling an estimated $49.6K and leaving 17,044 shares worth $8.63M. The position accounts for 0.13% of the portfolio, ranked #157.
Colony Group first reported a position in TMO in Q4 2013 and has held it in 39 quarters since. The position peaked at $11.8M in Q4 2022. 2,364 funds tracked by Wall St. Rank hold TMO as of Q3 2023.
- Colony Group held 17,044 shares of Thermo Fisher Scientific worth $8.63M as of Q3 2023.
- Colony Group sold 93 Thermo Fisher Scientific shares in Q3 2023, an estimated $49.6K.
- Thermo Fisher Scientific made up 0.13% of Colony Group's portfolio in Q3 2023, its #157 holding.
- Colony Group first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 39 quarters since.
- Colony Group's Thermo Fisher Scientific position peaked at $11.8M in Q4 2022.
- 2,364 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.
Based on Colony Group's 13F filing for Q3 2023, filed 14 Nov 2023.